Background
==========

Bladder cancer is the 10th most common cancer worldwide, with the highest rates reported in Europe, North America and Australia compared to Eastern countries \[[@B1],[@B2]\]; there are an estimated 261,000 new cases diagnosed and 115,000 deaths reported each year. The incidence of bladder cancer is highly correlated with increasing age. It rarely occurs before the age of 40 to 50 years of age, arising most commonly in the seventh decade of life \[[@B3],[@B4]\]. The median ages at diagnosis are 69 years for men and 71 for women \[[@B5]\].

MicroRNAs (miRNAs) are a class of 17 to 27 nucleotide single-stranded RNA molecules that regulate gene expression post-transcriptionally. A large body of evidence implicates aberrant miRNA expression patterns in most, if not all, human malignancies. Indeed, cancer is the result of a complex multistep process that involves the accumulation of sequential alterations of several genes and deregulation of those encoding miRNAs \[[@B6]\]. An increasing number of studies have demonstrated that microRNAs can function as potential oncogenes or oncosuppressor genes, depending on the cellular context and the target genes they regulate \[[@B7]\]. The first evidence of alterations of microRNA genes in human cancer came from studies of chronic lymphocytic leukemia (CLL). In a large study of indolent versus aggressive CLL, Calin et al. discovered a signature of 13 microRNAs capable of distinguishing between indolent and aggressive CLL \[[@B8]\]. For bladder cancer, Takahiro et al. demonstrated that KRT7 mRNA was significantly down-regulated by transfection of miR-30-3p, miR-133a and miR-199a in the bladder cancer cell line (KK47), suggesting that these three miRNAs may have a tumor suppressive role via the mechanism underlying transcriptional repression of KRT7 \[[@B9]\].

miRNAs and their target genes are usually validated by quantitative real time polymer transcriptase chain reaction (q-RT-PCR) and Western blot in a wet lab. However, wet lab works consumes a large amount of time and may not be able to obtain the desired results. Hence, we used text mining to identify nine miRNAs in bladder cancer and adopted protein-protein interaction analysis to identify interaction sites between these miRNAs and target genes. We obtained a long list of statistically significant genes without any unifying biological theme. Functional annotation of differentially expressed genes is a necessary and critical step in the analysis of microarray data \[[@B10]\]. A more judicious approach offers query-based access to an integrated database that disseminates biologically rich information across large datasets and displays graphic summaries of functional information. Therefore, we hope to find the important genes that are highly associated with the biological progression of bladder cancer through the use of bioinformatics tools.

Methods
=======

miRNAs in bladder cancer
------------------------

Bladder cancer related miRNAs were drawn from miR2Disease (<http://www.mir2disease.org>), which is a manually curated database providing a comprehensive resource of microRNA deregulation in various human diseases \[[@B11]\]. The current version of miR2Disease documents 1,939 curated relationships between 299 human microRNAs and 94 human diseases by reviewing more than 600 published papers.

Known targets of miRNA
----------------------

TarBase database houses a manually curated collection of experimentally tested miRNA targets in human/mouse, fruit fly, worm, and zebra fish, distinguishing between those that tested positive and those that tested negative \[[@B12]\]. A search for experimentally proven targets of nine bladder cancer-related miRNAs was performed using the TarBase database (<http://diana.cslab.ece.ntua.gr/tarbase>) (approved by the 452nd Hospital of People's Liberation Army).

KEGG pathway analysis
---------------------

The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment was determined by the Fisher exact test with a *P-*value less than 0.05. The KEGG pathway reveals that most target genes of miRNAs are located in the bladder cancer pathway including the Wnt pathway and cancer pathway. Based on this data, microRNA-regulated gene networks associated with bladder cancer were visualized by Cytoscape \[[@B13]\]. Cytoscape is an open source bioinformatics software platform for visualizing molecular interaction networks and integrating them with gene expression profiles and other state data. Only four miRNAs, including oncomiR miR-21, miR-101-3p, miR-221-3p and miR-133 were found in the miRNA-target genes network in this study. Among the remaining five miRNAs, miR-127 is usually differentially expressed as part of a miRNA cluster between normal cells and cancer cells \[[@B14]\]. Hence, we tried to study the functional mechanism of miR-127 in bladder cancer.

Target genes prediction
-----------------------

TargetScan is a well-known software for predicting microRNA targets from conserved UTR sequences \[[@B15]\], including software (miRanda) and database (microRNA.org). Additionally, starBase is a public platform for exploring miRNA-target interactions from CLIP-Seq (HITS-CLIP, PAR-CLIP) and degradome sequencing (PARE) data \[[@B16]\]. It also provides intersections of multiple target predictions, such as TargetScan, PicTar, miRanda, PITA, RNA22 and miRSVR. In this study, miRNA target genes were obtained from TargetScan (<http://www.targetscan.org>), miRanda (<http://www.microrna.org>), starBase (<http://www.starbase.sysu.edu.cn>) and miRDB (<http://www.mirdb.org>), respectively (Table [1](#T1){ref-type="table"}). The position of the target site was set in the 3\'UTR, with the context score −0.3.

###### 

Methods and resources for microRNA (miRNA) target prediction

  **Method**   **Type of method**     **References**   **Resource**
  ------------ ---------------------- ---------------- -----------------------------------
  TargetScan   seed complementarity   \[[@B15]\]       <http://www.targetscan.org>
  miRanda      complementarity        \[[@B17]\]       <http://www.microrna.org>
  StarBase     CLIP-Seq               \[[@B16]\]       <http://www.starbase.sysu.edu.cn>
  miRDB        thermodynamics^a^      \[[@B18]\]       <http://www.mirdb.org>

Secondary structures of miRNA binding sites
-------------------------------------------

We analyzed miRNA targets based on the common criteria, including seed-pairing, free energy of miRNA: target duplex, and proper dynamic programing score. To avoid the incongruency brought about by different standards or outcomes of RNA secondary structure and free energy predicted by distinct algorithms, we recalculated the secondary structures of miRNA. Of note, microRNA-response elements (MREs) involved in duplexes and their free energy for all predicted miRNAs were obtained from the online database by RNAcofold, which is a program for the prediction of hybrid structures of two RNA sequences (<http://www.tbi.univie.ac.at/ivo/RNA>) \[[@B19],[@B20]\]. Thus, we provided a relatively equal platform or prerequisite to compare the structure of all these microRNA targets.

Results
=======

Bladder cancer related miRNAs
-----------------------------

There are two relationship types between bladder cancer and its related miRNAs: causal and unspecified. In this study, data were filtered by selecting causal relationships between bladder cancer and microRNA. Of note, nine miRNAs such as hsa-miR-199a\*, hsa-miR-143, hsa-miR-127, hsa-miR-30-3p, hsa-miR-221, hsa-miR-21, hsa-miR-101, hsa-miR-129 and hsa-miR-133a were listed (Table [2](#T2){ref-type="table"}).

###### 

Bladder cancer related microRNAs (miRNAs) in miR2Disease

  **miRNA**       **Reference**   **Year**
  --------------- --------------- ----------
  hsa-miR-199a    \[[@B9]\]       2009
  hsa-miR-143     \[[@B21]\]      2009
  hsa-miR-127     \[[@B14]\]      2006
  hsa-miR-30-3p   \[[@B9]\]       2009
  hsa-miR-221     \[[@B22]\]      2009
  hsa-miR-21      \[[@B23]\]      2009
  hsa-miR-101     \[[@B24]\]      2009
  hsa-miR-129     \[[@B25]\]      2009
  hsa-miR-133a    \[[@B9]\]       2009

Target genes of nine miRNAs and their roles in the KEGG pathway
---------------------------------------------------------------

Target genes of nine selected miRNAs were obtained from TargetScan and starBase databases. Then, KEGG pathway analysis was applied to demonstrate the potential biological function of these target genes. Figure [1](#F1){ref-type="fig"} shows that target genes of four miRNAs such as hsa-miR-221, hsa-miR-30-3p, hsa-miR-133a and hsa-miR-21 were enriched in three pathways. The remaining five miRNAs annotated to the disease were not enriched in the KEGG pathways.

![**MicroRNA (miRNA) to mRNA network visualized by Cytoscape.** Pink dot represents target genes and red dot represents hub genes; yellow rectangle is miRNA; blue edge indicates target gene located in the pathway of human cancer; green edge means that target gene is located in the Wnt signaling pathway and orange edge that target gene is located in the bladder cancer pathway.](2047-783X-18-29-1){#F1}

Target prediction of miR-127
----------------------------

Given that miR-127 is highly embedded in a CpG island and numerous recent studies have revealed the role of miR-127 in human cancers \[[@B14],[@B26]\], we tried to focus on the study of target prediction of miR-127. Thirty eight target genes regulated by miR-127 were identified via five predicted software instruments including TargetScan, PicTar, PITA, miRanda and RNA22. We also identify the binding site of miR-127 and PIK3R1 in chromosome 5:67595672-67595693\[+\] (GRCh37/hg19) via CLIP-Seq datasets in the deepView genome browser (Figure [2](#F2){ref-type="fig"}).

![**Illustrative screen shots from the deepView browser.** The deepView browser provides an integrated view of CLIP-Seq data, known and predicted microRNA (miRNA) target sites, protein-coding genes, non-coding (ncRNA) genes, miRNAs, strand-specific peak clusters, genome-wide target-peaks and target-plots.](2047-783X-18-29-2){#F2}

In Figure [3](#F3){ref-type="fig"}, we compared the 38 predicted genes with cancer/bladder cancer related genes and then found that *PIK3R1* is the only one gene which overlapped among 38 genes in the bladder cancer pathway (Figure [4](#F4){ref-type="fig"}) and pathway of cancer (Figure [5](#F5){ref-type="fig"}). Therefore, we tried to describe miR-127 and its target gene *PIK3R1* and their mechanism of action in bladder cancer.

![**Venn diagram of 38 target genes of miR-127.** There are 42 genes in the bladder cancer pathway and 325 genes in the cancer pathway.](2047-783X-18-29-3){#F3}

![**Pathway in bladder cancer, without*PIK3R1*.**](2047-783X-18-29-4){#F4}

![**Pathway in cancer, includes*PIK3R1*.**](2047-783X-18-29-5){#F5}

The analysis of miRNA targets was based on the common criteria, including seed-pairing, free energy of miRNA, target duplex, and proper dynamic programing score. To avoid the incongruency brought about by different standards or outcomes of RNA secondary structure and free energy predicted by distinct algorithms, we recalculated the secondary structures of miRNA. MicroRNA-response element (MRE) duplexes and their free energy for all the predicted miRNAs were obtained from the online database by RNAcofold. The four most probably binding sites included SNP-56, −2236, −2611 and −3496. Additional file [1](#S1){ref-type="supplementary-material"}: Table S3.

Discussion
==========

We selected known targets of the nine miRNAs and demonstrated their roles in biological process via KEGG pathway analysis. The KEGG enrichment test showed three pathways to be related to the target genes of the four miRNAs. Only four miRNAs, including miR-21, miR-101-3p, miR-221-3p and miR-133 were in the miRNA-target genes network. MiR-127, one of the remaining five miRNAs, is usually differentially expressed as part of a miRNA cluster between normal cells and cancer cells \[[@B14]\]. Moreover, a predicted target of miR-127, proto-oncogene BCL6, was down-regulated after treatment with chromatin-modifying drugs \[[@B14]\]. In the current study, we focused on the study of the gene *PIK3R1* which was the only overlapping gene among 38 genes in the pathway of cancer.

PIK3R1, also known as GRB1, p85α, p85-ALPHA, is one of the core members involving the phosphoinositide 3-kinase (PI3K) pathway \[[@B27]\]. PI3K plays a pivotal role in cell growth, proliferation and survival and inter-signaling systems via this pathway are up-regulated in many types of cancer \[[@B28],[@B29]\]. It is strongly hypothesized that alterations of several pathway components can affect the normal function of the PI3K pathway. Knowles et al. has identified that alterations in pathway components PIK3CA, PTEN, AKT1 and TSC1 in bladder cancer are significantly related to tumor phenotype and clinical behavior \[[@B30]\]. PIK3R1 constitutively binds and inhibits the release of catalytic subunit p110 of PI3K. Mutation of PIK3R1 has been observed in ovarian and colon cancer \[[@B31]\], and higher kinase activity was detected in breast cancer \[[@B32]\]. Our findings confirm that the role of PIK3R1 can also be extrapolated in the biological process of bladder cancer.

However, no studies have investigated the role of genetic variations in this pathway in bladder cancer. In this project, we used a large case control study to evaluate the associations of a comprehensive catalog of single nucleotide polymorphisms (SNPs) in the PI3K pathway. Four binding sites of hsa-miR-127-3p including SNP-56, −2236, −2611 and −3496 were identified in the 3′ untranslated region of PIK3R1 mRNA, suggesting that single SNPs located at miRNA-binding sites are likely to affect the expression of their targets and might contribute to the pathogenesis of bladder cancer.

Conclusions
===========

Our data demonstrate a significant association between miR-127 and its target gene of PIK3R1 via analysis of the CLIP-Seq data, RNA secondary structure and free energy. The results indicate that miR-127 plays an important role in regulating PIK3R1 that is involved in both the cancer and bladder cancer pathways.
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